Guest Author
GPs can get much done to head off investor concerns before sitting at the negotiating table, writes communications adviser Joshua Rosen.
Private equity investment in the sector is attracting increasing attention from regulatory bodies as oversight intensifies at both federal and state levels, says Kirkland & Ellis's Dennis Williams.
The future of private equity in healthcare belongs to firms that can cultivate a specialist approach but still pivot to promising subsectors, believes Linden Capital Partners’ Tony Davis.
Most GPs tout their sector expertise, but Avista Healthcare Partners’ David Burgstahler asserts that such expertise needs to focus on specific subsectors to pay real dividends.
Easier access points, better education and a good dose of patience are what is required to unlock the potential of the private wealth channel, says iCapital’s managing director Kunal Shah.
The democratization of private equity is about expanding access to the asset class by solving the structural and operational barriers to investing, says Neuberger Berman’s Peter von Lehe.
The growth of evergreen vehicles, tailored educational support and the arrival of sector specialists are helping to open up private markets to individual investors, says Vista Equity Partners’ Dan Parant.
Despite potential fundraising challenges, there always is capital available for great opportunities, write McGuireWoods partner Jon Finger and managing director Rob Fox.
Knowing exactly why you want to co-invest, formalizing your strategy and making sure all the key ingredients are built into your program will go a long way toward making you a reliable, sought-after co-investor, write Meketa Investment Group's Steven Hartt and Ethan Samson.
The IRR clock starts ticking from day one, and the first months of a deal are critical to establishing its pace and trajectory and the relationship between the PE firm and portfolio company. Our firm has advised more than 200 PE funds since 1995, and even in the era of the 100-day plan, we time […]